Literature DB >> 26319826

HYPERTRIGLYCERIDEMIC WAIST PHENOTYPE AND CARDIOMETABOLIC ALTERATIONS IN BRAZILIAN ADULTS.

Anna Ligia Cabral Rocha1, Patricia Feliciano Pereira2, Milene Cristine Pessoa3, Rita de Cassia Gonçalves Alfenas4, Wellington Segheto5, Danielle Cristina Guimarães da Silva6, Marcio Pacheco Andrade7, Giana Zarbato Longo8.   

Abstract

AIMS: the present study aims to evaluate the prevalence of cardiometabolic changes according to the hypertriglyceridemic waist (HW) phenotype in Brazilian adults.
METHODS: it is a population based transversal study with 976 adults (n = 533 women) 20-59 years old. Phenotype was defined by triglycerides concentration (TGL) ≥ 150 mg/dl and waist circumference (WC) ≥80 cm in females and ≥ 90 cm in males. All the analyses were adjusted according to the study design and pondered by gender, age and schooling. A descriptive analysis was performed through averages and ratios; their respective confidence intervals were herein presented (CI 95%). The prevalence of cardiometabolic changes due to the presence of HW and to gender was calculated and compared by means of Pearson's chi-square test. Statistic significance level was 0.05. The probability of coronary event risk was estimated in 10 years and calculated from Framinghan score, using Kernel density graph.
RESULTS: no difference in phenotype prevalence between genders was observed. Higher averages in all the cardiometabolic risk factors analyzed and higher probability of evolving to a cardiovascular event in 10 years were observed in individuals with the HW phenotype. Lower HDL values were only verified in this group.
CONCLUSION: the HW phenotype is an important cardiovascular risk sign and allows the premature identification of individuals with higher risk, so that its use in clinical practice must be encouraged, mainly because it is a simple low cost asset. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26319826     DOI: 10.3305/nh.2015.32.3.9305

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  5 in total

1.  Hypertriglyceridemic waist phenotype and abnormal glucose metabolism: a system review and meta-analysis.

Authors:  Chun-Ming Ma; Xiao-Li Liu; Na Lu; Rui Wang; Qiang Lu; Fu-Zai Yin
Journal:  Endocrine       Date:  2019-05-07       Impact factor: 3.633

2.  Association of "hypertriglyceridemic waist" with increased 5-year risk of subclinical atherosclerosis in a multi-ethnic population: a prospective cohort study.

Authors:  Peyman Namdarimoghaddam; Adeleke Fowokan; Karin H Humphries; G B John Mancini; Scott Lear
Journal:  BMC Cardiovasc Disord       Date:  2021-02-02       Impact factor: 2.298

3.  Cardiometabolic risk in young adults from northern Mexico: Revisiting body mass index and waist-circumference as predictors.

Authors:  Abraham Wall-Medrano; Arnulfo Ramos-Jiménez; Rosa P Hernandez-Torres; Rafael Villalobos-Molina; Diana C Tapia-Pancardo; J Rafael Jiménez-Flores; A René Méndez-Cruz; Miguel Murguía-Romero; Itzell A Gallardo-Ortíz; René Urquídez-Romero
Journal:  BMC Public Health       Date:  2016-03-08       Impact factor: 3.295

4.  Hypertriglyceridemic waist phenotype in primary health care: comparison of two cutoff points.

Authors:  Marina Augusta Dias Braz; Jallyne Nunes Vieira; Flayane Oliveira Gomes; Priscilla Rafaella da Silva; Ohanna Thays de Medeiros Santos; Ilanna Marques Gomes da Rocha; Iasmin Matias de Sousa; Ana Paula Trussardi Fayh
Journal:  Diabetes Metab Syndr Obes       Date:  2017-09-12       Impact factor: 3.168

5.  Hypertriglyceridemic waist phenotype and associated factors in individuals with arterial hypertension and/or diabetes mellitus.

Authors:  Luiza Delazari Borges; Luma de Oliveira Comini; Laura Camargo de Oliveira; Heloísa Helena Dias; Emily de Souza Ferreira; Clara Regina Santos Batistelli; Glauce Dias da Costa; Tiago Ricardo Moreira; Rodrigo Gomes da Silva; Rosângela Minardi Mitre Cotta
Journal:  J Nutr Sci       Date:  2021-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.